Mylan has completed a merger with Upjohn. As a result of the merger, Viatris Inc. was formed. The shareholders of Mylan received about 43% of the shares of the merged company. Viatris shares will start trading on Nasdaq from November 17 under the ticker VTRS.

Mylan and Upjohn, a division of Pfizer, received all necessary merger approvals. After the merger, the new company will be called Viatris and its shares will be distributed among the shareholders of Pfizer - 57% and Mylan - 43%. On November 16, 2020, the merger will be completed and the shareholders of Mylan will receive one Viatris share instead of each of...

Net profit under GAAP for 9 months of 2020 was $245.9 million, against a loss of $3.7 million in the previous year. Revenue increased by 0.1% to $8.323 billion, against $8.309 billion a year earlier.

Чистая прибыль Mylan по GAAP за 3 мес. 2020 г. составила $20,8 млн., против убытка в $25 млн. в предыдущем году. Выручка увеличилась на 4,9% до $2,619 млрд. против $2,496 млрд. годом ранее.